ArticlePloS one2012

Natalizumab exerts direct signaling capacity and supports a pro-inflammatory phenotype in some patients with multiple sclerosis.

Thomas F Benkert et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.